Sanofi Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Sanofi stocks.

Sanofi Stocks Recent News

Date Stock Title
May 9 RGLS Regulus Therapeutics GAAP EPS of -$0.29
May 9 RGLS Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
May 9 MACK Merrimack Pharmaceuticals intends to declare $15.10 dividend
May 9 SNY Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash
May 9 MRK Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
May 9 ASND Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024
May 9 SNY Royalty Pharma pays startup $525M for stake in Sanofi MS drug
May 9 MACK Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
May 9 MRK Merck says Keytruda failed as first-line therapy for uterine cancer
May 9 MRK Health Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy
May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
May 9 MRK Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
May 8 SNY Sanofi chief scientific officer leaving company: report
May 8 SNY Sanofi's New Cancer Drug Could Help Deliver a Big Payday
May 8 MRK Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers
May 8 SNY Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
May 8 REGN Regeneron gene therapy improves hearing in child deafness
May 8 REGN Regeneron gene therapy improves hearing in two children
May 8 SNY Sanofi SA's Dividend Analysis
May 8 MRK Q1 2024 OPKO Health Inc Earnings Call
Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).

Browse All Tags